Fennec Pharmaceuticals Inc. Common Stock
$10.62
Market Cap
$378.02M
Shares Outstanding
35.1M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jan 28, 2002
Round Lot
100
Locale
US
Day Open
$10.78
Day High
$10.88
Day Low
$10.59
Volume
126.3K
VWAP
$10.66
Prev Close
$10.78
Transactions
--
Acc. Volume
--
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
Fennec Pharmaceuticals Inc. Common Stock (FENC) closed the 2026-09-18 session at $10.62, down 1.48% versus the previous close (-0.16). The stock opened at $10.78 and traded between $10.59 and $10.88 during that session. Session trading volume was 126K shares. The volume-weighted average price (VWAP) is $10.66.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
Fennec Pharmaceuticals Inc. Common Stock has a market capitalization of $378.0 million. The company operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry classification. FENC is listed on the XNAS exchange. The company employs approximately 35 people. Fennec Pharmaceuticals Inc. Common Stock is headquartered in RESEARCH TRIANGLE PARK, NC. The recorded listing date is 2002-01-28.
On this page you can find market FENC stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.